slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 67,711-67,740
Pages 3,679
Rows per page 30
Component
67,711-67,740 of 110,355
04
The slide uses a split-view layout to contrast the company's reach across brands and retailers.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
07
The slide uses a donut chart to illustrate market share and lists key service offerings for four business units.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide uses a dual-table layout to segment clients into 'Brands' and 'Retailers', emphasizing the longevity of these partnerships.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart displays revenue in millions for Q1, Q2, and Q3 of 2022.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The chart highlights two key conversion rates: ~53% for Unlevered Free Cash Flow and ~12% for Levered Free Cash Flow (Pre-M&A).Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
The slide uses a four-column layout to categorize strategic financial priorities.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
02
Includes a hub-and-spoke diagram illustrating the effects of pathogenic autoantibodies.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Problem Identification1 hit
03
The slide uses a visual process flow to explain the competitive inhibition mechanism.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
04
The slide uses a timeline-based process flow to illustrate the clinical trial protocol.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
08
The chart includes error bars and a table of participant counts at the bottom.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Before-After Comparison1 hit
09
The slide uses a stacked bar chart to visualize the response rates and a table to detail specific IWG criteria outcomes.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Comparative Analysis1 hit
12
The chart displays a significant, sustained reduction in IgG levels for the treatment group compared to placebo.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
14
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Key Takeaways1 hit
08
The slide uses a timeline framework to establish credibility and future-looking innovation.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Complication1 hit
11
The slide uses a process flow diagram to illustrate the randomization of patients into treatment arms.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
12
Includes a table of patients at risk below the x-axis and a summary table of PFS events, median PFS, and hazard ratio.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
13
Includes a table of PFS events, median PFS, and adjusted hazard ratio (HR) alongside the survival plot and risk table.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
14
Includes a risk table and summary statistics table (Median PFS, HR).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
15
Includes risk tables and hazard ratios (HR) with 95% confidence intervals.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
16
Includes a forest plot for subgroup analysis and a summary table for prior treatments.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Quick Win Big Bet1 hit
22
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
24
Clinical trial data visualization showing progression-free survival (PFS) curves with associated hazard ratios and event counts.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
40
The chart uses a forest plot format to visualize confidence intervals for multiple clinical endpoints.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
41
The chart uses a randomized withdrawal (RW) design to isolate the effect of drug discontinuation.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
42
The slide includes a footnote defining abbreviations and study parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
44
The slide uses a tree metaphor for the study name 'CYPRESS'.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
05
The slide uses a process-style arrow diagram to present three core financial metrics.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
The chart displays quarterly financial performance metrics for Vivid Seats.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
Includes a footnote regarding the absence of EPS data prior to October 18, 2021.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
18
The chart highlights specific quarters in blue (Q3 2019, Q3 2021, Q3 2022), likely to denote seasonality or specific comparison periods.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit